Détails du rapport Vaer
Âge: N/A
Genre: Female
Région : Outside US
- Patient décédé?
- Non
- Renseignements sur les vaccins
-
Nom: COVID19 (COVID19 (PFIZER-BIONTECH))
Type : Coronavirus 2019 vaccine
Fabricant: PFIZER
Lot: fk0596
- Date de réception du rapport
- 2022-03-04
- Date à laquelle le formulaire est complèté
- Date de vaccination
- 2021-11-11
- Date d’apparition
- 103
- Nombre de jours (date d’apparition – date de vaccination)
- 103
- Description de l’événement indésirable
-
drug ineffective; sars-cov-2 infection; this is a spontaneous report received from a contactable reporter(s) (consumer or other non hcp) from the regulatory authority (ra) and product quality group. the reporter is the patient. a 61 year-old female patient received bnt162b2 (comirnaty), administration date 11nov2021 (lot number: fk0596) as dose 3 (booster), single for covid-19 immunisation; covid-19 vaccine nrvv ad (chadox1 ncov-19) (covid-19 vaccine astrazeneca), administration date 07may2021 (batch/lot number: unknown) as dose 1 and administration date 13feb2021 (batch/lot number: unknown) as dose 2. relevant medical history included: "severe asthma attack", start date: nov2020 (unspecified if ongoing), notes: requiring hospitalisation nearly went to icu and were sure it was not covid but i thought it must be; "steroid therapy" (unspecified if ongoing), notes: taking regular steroid treatment (e.g. orally or rectally). take regular steroid inhalers and creams and occasional courses of steroid tablets; "immunodeficiency" (unspecified if ongoing), notes: taking other treatments or medicines, not listed above, known to lower the immune response; "asthma" (unspecified if ongoing). concomitant medication(s) included: influenza virus, administration date nov2021. past drug history included: methotrexate for fungal skin infection. the following information was reported: drug ineffective (medically significant) with onset 22feb2022, outcome "not recovered", described as "drug ineffective"; suspected covid-19 (medically significant) with onset 22feb2022, outcome "not recovered", described as "sars-cov-2 infection". the patient underwent the following laboratory tests and procedures: sars-cov-2 test: no - negative covid-19 test. additional information: patient had not had symptoms associated with covid-19 and was not enrolled in clinical trial. no follow-up attempts are possible. no further information is expected.; sender's comments: linked report(s) : gb-pfizer inc-202200323366 same patient, same product, different dose/events
- Données de laboratoire
-
test name: covid-19 virus test; result unstructured data: test result:no - negative covid-19 test
- Liste des symptômes
-
drug ineffective sars-cov-2 test suspected covid-19
- Patient décédé?
- Non
- Date de décès
- N/A
- Anomalie congénitale
- false
- Vaccin administré par :
- Other
- Vaccin acheté par :
- Inconnu
- Visite d’un patient à l’urgence?
- Non
- Patient hospitalisé?
- Non
- Séjour à l’hôpital
- Non
- Nombre de jours à l’hôpital
- Non spécifié
- Invalidité permanente?
- Non
- Allergies:
-
na
- Maladie actuelle
-
na